SCHEMBL6002934

SCHEMBL6002934

C[C](c1ccc(F)cc1)c1ccccc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.46
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPT P10636 3/20 0.40
GAA P10253 2/20 0.40
RAB9A P51151 2/20 0.40
NPC1 O15118 2/20 0.40
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MT-CO2 P00403 1/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
CYP3A4 P08684 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20659154 0.84 ALDH1A1 (0.52) CES2CES1KMT2AALDH1A1CYP1A2
SCHEMBL10389925 0.81 HSD11B1 (0.46) HSD11B1CES2CES1KMT2AALDH1A1
SCHEMBL20661617 0.80 LMNA (0.46) HSD11B1CES2CES1KMT2AALDH1A1
SCHEMBL5408652 0.79 CES2 (0.56) CES2CES1KMT2AALDH1A1CYP1A2
SCHEMBL7470787 0.78 KMT2A (0.54) KMT2AALDH1A1CYP1A2CYP2D6TSHR
SCHEMBL20659162 0.78 GAA (0.41) CES2CES1KMT2AALDH1A1MAPT
SCHEMBL9592939 0.78 MEN1 (0.49) KMT2AALDH1A1TSHRMAPTRAB9A
SCHEMBL29375774 0.77 KMT2A (0.62) HSD11B1CES2CES1KMT2AALDH1A1
SCHEMBL333687 0.77 KMT2A (0.62) HSD11B1CES2CES1KMT2AALDH1A1
SCHEMBL20659147 0.76 ALDH1A1 (0.47) CES2CES1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed